Investor Presentaiton slide image

Investor Presentaiton

Company overview Financial review 2022 priorities Appendix References Harry Kirsch Chief Financial Officer Financial review and 2022 guidance 20 Investor Relations | Q2 2022 Results NOVARTIS | Reimagining Medicine
View entire presentation